Device Trial Radar · NCT06652750
Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices
Last checked: Nov 20, 2026Latest source record: Nov 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
688
Planned (sponsor's estimate)
Start
Nov 13, 2024
Primary completion
Feb 1, 2025
Study completion Feb 1, 2026
Sponsor
- Lead sponsor
- The Third People's Hospital of ChengduAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 22, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Health services research
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Objective: This clinical study employs a prospective, paired, self-controlled, non-inferiority, multicenter research design to assess the safety and efficacy of utilizing 5G cloud follow-up for CIED in parameters monitoring and remote programming post-implantation. Participants will: undergo regular clinic follow-up visits in accordance with the guidelines undergo routine in-office follow-up and 5G cloud follow-up during each regular clinic visit
Conditions
- Sick Sinus Syndrome
- Atrioventricular Block, Second and Third Degree
- Heart Failure
Interventions
Routine ManagementOther
Conducting routine in-office follow-up for CIED paitents
5G Cloud Follow-upDevice
This study employed a 5G-cloud follow-up platform, a research tool that allows a device specialist to test, and program CIEDs in real-time from a remote location via an internet connection or mobile wireless network. Consistent with of the 5G remote support terminal externally connected to the programmer, a PAD was installed with a 5G-cloud follow-up app. The onsite medical staff began the cloud follow-up session by contacting the remote device specialist via video call. The connection to the CIED was made by the medical staff through the use of a standard programmer. He was in charge of turning on the programmer and applying the programmer wand to the patient's device. After an initial introduction, communication was established and continued via the wand connection. The remote device specialist logged into the 5G-cloud follow-up app with two-step verification. The remote device specialist then had complete control of the programmer to check and reprogram the device as needed.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Parameter Measurement ConsistencyTime frame: through study completion, an average of 1 year
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Sun Yat-sen Memorial Hospital
Guangzhou, Guangdong, China · Recruiting
The Third People's Hospital of Chengdu
Chengdu, Sichuan, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.